Nanomedicine applications in the treatment of breast cancer: current state of the art
Di Wu, Mengjie Si, Hui-Yi Xue, Ho-Lun Wong Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA, USA Abstract: Breast cancer is the most common malignant disease in women worldwide, but the current drug therapy is far from optimal as indicated by the high d...
Saved in:
| Main Authors: | Wu D, Si M, Xue H, Wong HL |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/2782023edd084843a48ad324a8e2dccd |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models
by: Sayoni Maitra Roy, et al.
Published: (2021) -
Hybrid Molecularly Imprinted Polymers: The Future of Nanomedicine?
by: Maylis Garnier, et al.
Published: (2021) -
Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System
by: Jinxiu Li, et al.
Published: (2021) -
Synergistic Cascade Strategy Based on Modifying Tumor Microenvironment for Enhanced Breast Cancer Therapy
by: Huan Zhang, et al.
Published: (2021) -
Commercial utilities and future perspective of nanomedicines
by: Rishabha Malviya, et al.
Published: (2021)